1. Home
  2. ANGI vs HELP Comparison

ANGI vs HELP Comparison

Compare ANGI & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$6.84

Market Cap

266.7M

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$5.10

Market Cap

249.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANGI
HELP
Founded
1995
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
266.7M
249.0M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ANGI
HELP
Price
$6.84
$5.10
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$17.00
$95.00
AVG Volume (30 Days)
1.0M
1.2M
Earning Date
05-05-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
1242.86
N/A
EPS
0.94
N/A
Revenue
$736,386,000.00
N/A
Revenue This Year
$3.25
N/A
Revenue Next Year
$3.76
N/A
P/E Ratio
$7.29
N/A
Revenue Growth
47.60
N/A
52 Week Low
$6.43
$4.29
52 Week High
$19.42
$8.55

Technical Indicators

Market Signals
Indicator
ANGI
HELP
Relative Strength Index (RSI) 33.69 46.84
Support Level N/A $4.41
Resistance Level $8.19 $7.28
Average True Range (ATR) 0.39 0.32
MACD 0.04 0.09
Stochastic Oscillator 23.86 85.57

Price Performance

Historical Comparison
ANGI
HELP

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Share on Social Networks: